Vertex Pharmaceuticals Inc / Ma financial data

Symbol
VRTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
50 Northern Avenue, Boston, Massachusetts
State of incorporation
Massachusetts
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 392 % -14.3%
Quick Ratio 19.9 % +24.2%
Debt-to-equity 30.3 % +0.17%
Return On Assets 18.1 % -3.51%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 258 M shares +0.2%
Common Stock, Shares, Outstanding 258 M shares +0.31%
Entity Public Float 90.7 B USD +26.3%
Common Stock, Value, Issued 2.6 M USD 0%
Weighted Average Number of Shares Outstanding, Basic 258 M shares +0.31%
Weighted Average Number of Shares Outstanding, Diluted 261 M shares +0.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.2 B USD +10.6%
Research and Development Expense 3.2 B USD +74.1%
Costs and Expenses 5.99 B USD +16.1%
Operating Income (Loss) 4.19 B USD +3.63%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.77 B USD +14.4%
Income Tax Expense (Benefit) 748 M USD -17.7%
Net Income (Loss) Attributable to Parent 4.02 B USD +23.3%
Earnings Per Share, Basic 15.6 USD/shares +22.8%
Earnings Per Share, Diluted 15.4 USD/shares +22.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.16 B USD -1.42%
Marketable Securities, Current 1.01 B USD -9.87%
Accounts Receivable, after Allowance for Credit Loss, Current 1.79 B USD +15.9%
Inventory, Net 813 M USD +52%
Other Assets, Current 84.3 M USD +13.3%
Assets, Current 13.3 B USD +2.49%
Deferred Income Tax Assets, Net 1.96 B USD +44.3%
Operating Lease, Right-of-Use Asset 313 M USD -6.96%
Intangible Assets, Net (Excluding Goodwill) 835 M USD +38.3%
Goodwill 1.09 B USD 0%
Other Assets, Noncurrent 876 M USD +105%
Assets 23.9 B USD +26.1%
Accounts Payable, Current 351 M USD +8.73%
Employee-related Liabilities, Current 295 M USD +19.7%
Accrued Liabilities, Current 2.8 B USD +20.2%
Liabilities, Current 3.8 B USD +25.4%
Operating Lease, Liability, Noncurrent 360 M USD -3.18%
Other Liabilities, Noncurrent 854 M USD +17.5%
Liabilities 5.37 B USD +18.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 17.3 M USD
Retained Earnings (Accumulated Deficit) 11.2 B USD +55.7%
Stockholders' Equity Attributable to Parent 18.5 B USD +28.5%
Liabilities and Equity 23.9 B USD +26.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.31 B USD +45.2%
Net Cash Provided by (Used in) Financing Activities -358 M USD -21.3%
Net Cash Provided by (Used in) Investing Activities -2.14 B USD -16.5%
Common Stock, Shares Authorized 500 M shares 0%
Common Stock, Shares, Issued 258 M shares +0.31%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.2 B USD +1.11%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.17 B USD -1.36%
Interest Paid, Excluding Capitalized Interest, Operating Activities 10 M USD -9.91%
Deferred Tax Assets, Valuation Allowance 267 M USD +12.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 2.43 B USD +31.9%
Operating Lease, Liability 382 M USD -10.8%
Depreciation 168 M USD +13.1%
Payments to Acquire Property, Plant, and Equipment 68.4 M USD +62.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.05 B USD +25.2%
Lessee, Operating Lease, Liability, to be Paid 436 M USD -11.2%
Operating Lease, Liability, Current 33.1 M USD -31.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 41.4 M USD -6.55%
Lessee, Operating Lease, Liability, to be Paid, Year One 42.1 M USD -27.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Deferred Income Tax Expense (Benefit) -537 M USD -94.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 54.4 M USD -13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 40.4 M USD +0.5%
Deferred Tax Assets, Operating Loss Carryforwards 77.4 M USD -27.4%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -570 M USD -41.1%
Current Income Tax Expense (Benefit) 1.3 B USD +9.31%
Preferred Stock, Shares Authorized 1 M shares 0%
Unrecognized Tax Benefits 616 M USD +34%
Lessee, Operating Lease, Liability, to be Paid, Year Four 36.5 M USD -7.36%
Operating Lease, Payments 62.8 M USD +23.6%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 46.2 M USD +32.4%
Current Federal Tax Expense (Benefit) 900 M USD +15.6%
Amortization of Intangible Assets 1.7 M USD
Depreciation, Depletion and Amortization 53.5 M USD +37.9%
Deferred Tax Assets, Net of Valuation Allowance 2.17 B USD +34.9%
Share-based Payment Arrangement, Expense 651 M USD +34.6%
Deferred State and Local Income Tax Expense (Benefit) -21.9 M USD -99.1%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%